甲状腺癌靶向治疗进展  

Commentary on the progress of targeted therapy for thyroid cancer

作　　者：李浩[1] 聂荣成 张诠[1] LI Hao;NIE Rongcheng;ZHANG Quan(Author's Affiliation:Department of Head and Neck,the Cancer Center of Sun Yat-sen University,Guang-zhou,Guangdong,China,510060)

机构地区：[1]中山大学肿瘤防治中心头颈科,广东广州510060

出　　处：《分子诊断与治疗杂志》2021年第3期504-508,共5页Journal of Molecular Diagnostics and Therapy

基　　金：广东省科技计划项目(2016A020215090)。

摘　　要：甲状腺癌是头颈部常见的恶性肿瘤,也是内分泌系统中最常见的恶性肿瘤,其病理类型较多,不同类型的肿瘤在临床表现及治疗方法等方面差异较大。甲状腺癌的治疗主要采取以手术为主的综合治疗,但仍存在局限性。近年来,在晚期甲状腺癌的治疗中,靶向治疗逐渐发展,在延长患者的生存时间,改善患者的生存质量等方面发挥着重要作用。本文回顾目前靶向治疗在甲状腺癌治疗中的应用并对其进行概述,以加深临床工作者们对甲状腺癌靶向治疗的认识,推动靶向治疗在临床治疗中的合理应用。Thyroid cancer is a common malignant tumor in the head and neck and the most common malignant tumor in the endocrine system. There are many types of pathology,and different types of tumors differ greatly in clinical manifestations and treatment methods. The treatment of thyroid cancer mainly adopts comprehensive treatment based on surgery,but its limitations still exist. Recent years,in the treatment of advanced thyroid cancer,targeted therapy has gradually developed,which plays an important role in extending the survival time of patients and improving the quality of life of patients. This article reviews the current application of targeted therapy in the treatment of thyroid cancer to outline it,to deepen clinicians. understanding of targeted therapy and promote the rational application of targeted therapy in clinical treatment.

关 键 词：分化型甲状腺癌 甲状腺髓样癌 未分化甲状腺癌 靶向治疗 治疗效果 

分 类 号：R736.1[医药卫生—肿瘤]